Whit Mayo
Stock Analyst at Leerink Partners
(2.55)
# 2,141
Out of 5,174 analysts
158
Total ratings
52%
Success rate
10.28%
Average return
Main Sectors:
Stocks Rated by Whit Mayo
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ARDT Ardent Health | Maintains: Outperform | $16 → $15 | $8.59 | +74.62% | 3 | Mar 6, 2026 | |
| CLOV Clover Health Investments | Maintains: Market Perform | $3 → $2.5 | $1.82 | +37.36% | 5 | Mar 5, 2026 | |
| AHCO AdaptHealth | Maintains: Outperform | $13 → $12 | $11.48 | +4.53% | 12 | Feb 26, 2026 | |
| ACHC Acadia Healthcare Company | Maintains: Market Perform | $14 → $22 | $22.69 | -3.04% | 12 | Feb 26, 2026 | |
| EHAB Enhabit | Maintains: Market Perform | $9.5 → $14 | $13.66 | +1.02% | 3 | Feb 23, 2026 | |
| THC Tenet Healthcare | Maintains: Outperform | $255 → $264 | $199.63 | +32.24% | 15 | Feb 20, 2026 | |
| MD Pediatrix Medical Group | Maintains: Market Perform | $15 → $17 | $20.75 | -18.07% | 11 | Sep 5, 2025 | |
| ELV Elevance Health | Downgrades: Market Perform | $510 → $310 | $290.33 | +6.78% | 4 | Jul 18, 2025 | |
| AIRS AirSculpt Technologies | Maintains: Market Perform | $6.5 → $2.5 | $2.82 | -11.35% | 5 | Mar 31, 2025 | |
| HUM Humana | Downgrades: Market Perform | $400 → $250 | $172.23 | +45.15% | 12 | Oct 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $100 | $97.49 | +2.57% | 1 | Jul 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $15 | $43.31 | -65.37% | 1 | Feb 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $625 → $560 | $272.28 | +105.67% | 11 | Jun 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $185.92 | - | 11 | May 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $98 → $97 | $126.28 | -23.19% | 1 | Apr 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $309 → $335 | $265.87 | +26.00% | 5 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $238 → $286 | $485.72 | -41.12% | 17 | Dec 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $55 → $40 | $12.00 | +233.33% | 7 | Nov 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $46 → $39 | $21.03 | +85.45% | 7 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $33 → $30 | $0.44 | +6,764.99% | 5 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $235 → $175 | $76.76 | +127.98% | 1 | Apr 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $19 | $17.42 | +9.07% | 1 | Apr 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $5 → $4 | $2.92 | +36.99% | 6 | Jul 30, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Outperform | $183 → $203 | $266.12 | -23.72% | 2 | May 1, 2018 |
Ardent Health
Mar 6, 2026
Maintains: Outperform
Price Target: $16 → $15
Current: $8.59
Upside: +74.62%
Clover Health Investments
Mar 5, 2026
Maintains: Market Perform
Price Target: $3 → $2.5
Current: $1.82
Upside: +37.36%
AdaptHealth
Feb 26, 2026
Maintains: Outperform
Price Target: $13 → $12
Current: $11.48
Upside: +4.53%
Acadia Healthcare Company
Feb 26, 2026
Maintains: Market Perform
Price Target: $14 → $22
Current: $22.69
Upside: -3.04%
Enhabit
Feb 23, 2026
Maintains: Market Perform
Price Target: $9.5 → $14
Current: $13.66
Upside: +1.02%
Tenet Healthcare
Feb 20, 2026
Maintains: Outperform
Price Target: $255 → $264
Current: $199.63
Upside: +32.24%
Pediatrix Medical Group
Sep 5, 2025
Maintains: Market Perform
Price Target: $15 → $17
Current: $20.75
Upside: -18.07%
Elevance Health
Jul 18, 2025
Downgrades: Market Perform
Price Target: $510 → $310
Current: $290.33
Upside: +6.78%
AirSculpt Technologies
Mar 31, 2025
Maintains: Market Perform
Price Target: $6.5 → $2.5
Current: $2.82
Upside: -11.35%
Humana
Oct 2, 2024
Downgrades: Market Perform
Price Target: $400 → $250
Current: $172.23
Upside: +45.15%
Jul 10, 2024
Initiates: Outperform
Price Target: $100
Current: $97.49
Upside: +2.57%
Feb 20, 2024
Initiates: Outperform
Price Target: $15
Current: $43.31
Upside: -65.37%
Jun 14, 2023
Maintains: Outperform
Price Target: $625 → $560
Current: $272.28
Upside: +105.67%
May 26, 2023
Upgrades: Outperform
Price Target: n/a
Current: $185.92
Upside: -
Apr 3, 2023
Maintains: Overweight
Price Target: $98 → $97
Current: $126.28
Upside: -23.19%
Feb 8, 2023
Maintains: Market Perform
Price Target: $309 → $335
Current: $265.87
Upside: +26.00%
Dec 16, 2022
Maintains: Outperform
Price Target: $238 → $286
Current: $485.72
Upside: -41.12%
Nov 22, 2022
Maintains: Outperform
Price Target: $55 → $40
Current: $12.00
Upside: +233.33%
Nov 11, 2022
Maintains: Outperform
Price Target: $46 → $39
Current: $21.03
Upside: +85.45%
Nov 4, 2022
Maintains: Outperform
Price Target: $33 → $30
Current: $0.44
Upside: +6,764.99%
Apr 4, 2022
Maintains: Overweight
Price Target: $235 → $175
Current: $76.76
Upside: +127.98%
Apr 4, 2022
Initiates: Outperform
Price Target: $19
Current: $17.42
Upside: +9.07%
Jul 30, 2018
Maintains: Neutral
Price Target: $5 → $4
Current: $2.92
Upside: +36.99%
May 1, 2018
Assumes: Outperform
Price Target: $183 → $203
Current: $266.12
Upside: -23.72%